After losing in US court, LLY is arguing the Gemzar patent case against HSP before the ITC: http://www.bloomberg.com/news/2011-03-17/lilly-claim-over-hospira-s-gemzar-copy-to-be-reviewed-by-itc-1-.html Although unlikely, a recommendation by the ITC to impede the importation of generic Gemzar into the US would be a terrible precedent, IMO.